eISSN: 2345-2781  
Submitted: 07 Jan 2018

Accepted: 05 Feb 2018
First published online: 08 Feb 2018
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Abstract Page Views: 126
PDF Downloads: 98
Full Text Views: 0
J Renal Inj Prev. 2018;7(4):324-325.
doi: 10.15171/jrip.2018.70

Commentary

N-acetylcysteine and residual kidney function among end-stage kidney failure

Seyed Seifollah Beladi Mousavi 1,2, Seyed Majid Mousavi Movahhed 2 * , Leila Sabetnia 1, Fatemeh Hyati 1

1 Chronic Renal Failure Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Internal Medicine, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding author: Seyed Majid Mousavi Movahhed, Email; Email: beladimusavi@yahoo.com

Implication for health policy/practice/research/medical education:

Preserving residual kidney function (RKF) is an important goal among end-stage kidney failure (ESKF) patients and it has been increasingly incriminated to be important in maintaining fluid balance, removal of middle molecular uremic toxins, nutritional condition and well-being of patients on dialysis. Therefore more attention should be focused on preserving RRF even after patients are started on dialysis

Please cite this paper as: Beladi Mousavi SS, Mousavi Movahhed SM, Sabetnia L, Hyati F. N-acetylcysteine and residual kidney function among end-stage kidney failure. J Renal Inj Prev. 2018;7(4):324-325. DOI: 10.15171/jrip.2018.70.

First name
 
Last name
 
Email address
 
Comments
 
Security code